These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36476261)

  • 1. An observational study of the extent of naloxone furnishing in California Central Valley community pharmacies.
    Banawis M; Mah G; Mohsin R; Pobre J; Tracy D; Song AV; Apollonio DE
    J Am Pharm Assoc (2003); 2023; 63(2):566-573. PubMed ID: 36476261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist furnishing of hormonal contraception in California's Central Valley.
    Azad A; Su J; Nguyen M; Ly M; Wu I; Tracy D; Song A; Apollonio DE
    J Am Pharm Assoc (2003); 2024; 64(1):226-234.e2. PubMed ID: 37595885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of naloxone furnishing community pharmacies in San Francisco.
    Nguyen AM; Kearney TE; Apollonio DE
    J Am Pharm Assoc (2003); 2020; 60(6):1050-1057.e1. PubMed ID: 32948461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist furnishing of naloxone in California: A follow-up analysis.
    Puzantian T; Gasper JJ; Ramirez CM
    J Am Pharm Assoc (2003); 2021; 61(5):e108-e112. PubMed ID: 34246575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An observational survey assessing the extent of PrEP and PEP furnishing in San Francisco Bay Area pharmacies.
    Bellman R; Mohebbi S; Nobahar N; Parizher J; Apollonio DE
    J Am Pharm Assoc (2003); 2022; 62(1):370-377.e3. PubMed ID: 34429253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State laws that authorize pharmacists to prescribe naloxone are associated with increased naloxone dispensing in retail pharmacies.
    Xu J; Mukherjee S
    Drug Alcohol Depend; 2021 Oct; 227():109012. PubMed ID: 34482035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacy naloxone codispensing: A mixed methods study of practices and perspectives under a statewide standing order program.
    Pollini RA; Slocum S; Ozga JE; Joyce R; Xuan Z; Green TC; Walley AY
    J Am Pharm Assoc (2003); 2022; 62(5):1546-1554. PubMed ID: 35450833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama.
    Sisson ML; McMahan KB; Chichester KR; Galbraith JW; Cropsey KL
    Int J Drug Policy; 2019 Dec; 74():229-235. PubMed ID: 31698165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparing pharmacists to increase naloxone dispensing within community pharmacies under the Pennsylvania standing order.
    Santa HM; Amirova SG; Ventricelli DJ; Downs GE; Nowalk AA; Pringle JL; Aruru M
    Am J Health Syst Pharm; 2021 Feb; 78(4):327-335. PubMed ID: 33336254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone accessibility without an outside prescription from U.S. community pharmacies: A systematic review.
    Lai RK; Friedson KE; Reveles KR; Bhakta K; Gonzales G; Hill LG; Evoy KE
    J Am Pharm Assoc (2003); 2022; 62(6):1725-1740. PubMed ID: 35989151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of naloxone access, pricing, and barriers to dispensing in Tennessee retail community pharmacies.
    Spivey CA; Wilder A; Chisholm-Burns MA; Stallworth S; Wheeler J
    J Am Pharm Assoc (2003); 2020; 60(5):694-701.e1. PubMed ID: 32146134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic.
    Dadiomov D; Bolshakova M; Mikhaeilyan M; Trotzky-Sirr R
    Harm Reduct J; 2022 Jun; 19(1):69. PubMed ID: 35768817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying barriers to dispensing naloxone: A survey of community pharmacists in North Carolina.
    Rudolph SE; Branham AR; Rhodes LA; Hayes HH; Moose JS; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S55-S58.e3. PubMed ID: 30006187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacists and Naloxone: Barriers to Dispensing and Effectiveness of an Educational Outreach Program.
    Hanson KA; Smart MH; Mandava MR; Carkovic E; Aslamy M; Lee TA; Pickard AS
    J Am Pharm Assoc (2003); 2023; 63(2):608-613.e3. PubMed ID: 36631342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies.
    Green TC; Bratberg J; Irwin AN; Boggis J; Gray M; Leichtling G; Bolivar D; Floyd A; Al-Jammali Z; Arnold J; Hansen R; Hartung D
    Subst Abus; 2022; 43(1):901-905. PubMed ID: 35213293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of hormonal contraceptive furnishing in San Francisco community pharmacies.
    Chen L; Lim J; Jeong A; Apollonio DE
    J Am Pharm Assoc (2003); 2020; 60(6):963-968.e2. PubMed ID: 32800456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of academic detailing for pharmacists on opioid use disorder and harm reduction.
    DiPaula BA; Cooke CE; Boyle CJ; Love RC
    J Am Pharm Assoc (2003); 2022; 62(1):241-246. PubMed ID: 34690080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings.
    Bailey AM; Wermeling DP
    Ann Pharmacother; 2014 May; 48(5):601-6. PubMed ID: 24523396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.
    Bachyrycz A; Shrestha S; Bleske BE; Tinker D; Bakhireva LN
    Subst Abus; 2017; 38(1):55-60. PubMed ID: 27164192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ensuring buprenorphine access in rural community pharmacies to prevent overdoses.
    Ostrach B; Potter R; Wilson CG; Carpenter D
    J Am Pharm Assoc (2003); 2022; 62(2):588-597.e2. PubMed ID: 34674965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.